 | Drugs that reverse the omic signatures associated with dyslipidemia are shown to also restore physiological markers to their normal baselines. This provides a sound basis to computational methods that identify compounds which reverse a disease's omic signatures as potential therapeutic agents. Allon Wagner, Noa Cohen, Thomas Kelder, Uri Amit, Elad Liebman, David M Steinberg, Marijana Radonjic, and Eytan Ruppin |
No comments:
Post a Comment